In human AF, NOX2 has also been demonstrated to participate in the atrial structural remodeling and electrophysiological remodeling, and up-regulation of NOX2 is associated with an enhanced risk of AF [49, 50]. The gene discussed is CYBB; the disease is atrial fibrillation.